Cargando…
Identifying Genetic Biomarkers Predicting Response to Anti-Vascular Endothelial Growth Factor Injections in Diabetic Macular Edema
Intraocular anti-vascular endothelial growth factor (VEGF) therapies are the front-line treatment for diabetic macular edema (DME); however, treatment response varies widely. This study aimed to identify genetic determinants associated with anti-VEGF treatment response in DME. We performed a genome-...
Autores principales: | Gurung, Rajya L., FitzGerald, Liesel M., Liu, Ebony, McComish, Bennet J., Kaidonis, Georgia, Ridge, Bronwyn, Hewitt, Alex W., Vote, Brendan J., Verma, Nitin, Craig, Jamie E., Burdon, Kathryn P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999697/ https://www.ncbi.nlm.nih.gov/pubmed/35409401 http://dx.doi.org/10.3390/ijms23074042 |
Ejemplares similares
-
The effect of insulin on response to intravitreal anti-VEGF injection in diabetic macular edema in type 2 diabetes mellitus
por: Gurung, Rajya L., et al.
Publicado: (2022) -
Predictive factors for treatment outcomes with intravitreal anti-vascular endothelial growth factor injections in diabetic macular edema in clinical practice
por: Gurung, Rajya L, et al.
Publicado: (2023) -
Identifying Genetic Risk Factors for Diabetic Macular Edema and the Response to Treatment
por: Gurung, Rajya L., et al.
Publicado: (2020) -
Comparing vision and macular thickness in neovascular age-related macular degeneration, diabetic macular oedema and retinal vein occlusion patients treated with intravitreal antivascular endothelial growth factor injections in clinical practice
por: Gurung, Rajya L, et al.
Publicado: (2021) -
The Association Between Vitamin D and Multiple Sclerosis Risk: 1,25(OH)(2)D(3) Induces Super-Enhancers Bound by VDR
por: Lu, Ming, et al.
Publicado: (2019)